Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-3599
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age ; day:13 ; month:12 ; year:2016 ; pages:1-7
Journal of genetic counseling ; (13.12.2016), 1-7
- Creator
-
Erkelens, A. van
- Contributor
-
Derks, L.
Sie, A. S.
Egbers, L.
Woldringh, G.
Prins, J. B.
Manders, P.
Hoogerbrugge, N.
SpringerLink (Online service)
- DOI
-
10.1007/s10897-016-0049-4
- URN
-
urn:nbn:de:1111-201701096154
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Erkelens, A. van
- Derks, L.
- Sie, A. S.
- Egbers, L.
- Woldringh, G.
- Prins, J. B.
- Manders, P.
- Hoogerbrugge, N.
- SpringerLink (Online service)
Other Objects (12)
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
Clinical application value of expanded carrier screening in the population of childbearing age
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
Clinical application value of expanded carrier screening in the population of childbearing age
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
Clinical application value of expanded carrier screening in the population of childbearing age